Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011841) titled 'EVALUATING IMMUNOLOGICAL PROFILES ASSOCIATED WITH RECAPTURE OF CLINICAL RESPONSE AT WEEK 24 IN ULCERATIVE COLITIS PATIENTS WITH SECONDARY LOSS OF RESPONSE TO VEDOLIZUMAB' on April 13.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Yonsei University Health System, Severance Hospital
Condition:
Diseases of the digestive system
Intervention:
Biological/Vaccine, Non-Stem Cell : This is a prospective, randomized, open label, multi-center, phase IV study in Korean adult patients with moderately to...